%0 Journal Article
%T Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause.
%A Stute P
%A Bertschy S
%A Birkhaeuser M
%A Bitzer J
%A Ging A
%A Raggi A
%A Steimann S
%A Stute V
%J Climacteric
%V 25
%N 3
%D 06 2022
%M 34907824
%F 3.024
%R 10.1080/13697137.2021.2008894
%X Genitourinary syndrome of menopause (GSM) has a significantly negative impact on affected women's lives. However, despite the increasing number of GSM treatment options (e.g. non-hormonal vaginal products, vaginal hormones [estrogens], dehydroepiandrosterone [DHEA; prasterone], vaginal laser therapy, oral ospemifene), many women remain untreated. The goal of the Swiss interdisciplinary GSM consensus meeting was to develop tools for GSM management in daily practice: a GSM management algorithm (personalized medicine); a communication tool for vaginal DHEA (drug facts box); and a communication tool for understanding regulatory authorities and the discrepancy between scientific data and package inserts. The acceptance and applicability of such tools will be further investigated.